Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Breath or Urine Analysis May Indicate Disease

By LabMedica International staff writers
Posted on 18 Mar 2009
A sensor is being developed that will be able to analyze a patient's breath or urine to determine whether the patient has breast cancer, lung cancer, diabetes, or asthma. More...


The sensor device, known as the optofluidic ring resonator (OFRR), is an optical gas sensor that consists of a polymer-lined glass tube that guides the flow of a gas vapor, and a ring resonator that detects the molecules that pass through the glass tube. As the gas vapor enters the device, molecules in the vapor separate and react to the polymer lining. Light makes thousands of loops around the gas or liquid sample. The more the light loops around the sample, the more the light energy interacts with the gas vapor. These repetitive interactions enable the detection of a very small number of vapor molecules.

The device is being developed by Professor Xudong "Sherman" Fan, a University of Missouri (Columbia, MO, USA) scientist. It will analyze breath or urine samples for volatile markers inside the body that indicate disease. The markers, such as alkanes, acetones, or nitric oxide, give doctors information about what is happening inside the body and can be used as a diagnostic tool.

"Little traces of certain gas molecules in the breath or urine tell us if anything unusual is going on in the body," said Professor Fan. "Measuring these volatile markers would be a noninvasive way to determine if a disease is present without having to draw blood or complete a biopsy. In addition to the biomarkers already discovered, many more potential volatile markers are still under investigation."

Optical gas sensors have broad applications in the fields of medical care, industry, military, environment, and homeland security. In addition to OFRR's application in the medical industry, the device also can improve the detection of explosives on the battlefield. Currently, the existing gas vapor sensor technology is very bulky with equipment weighing more than 100 pounds and is difficult to use in the field.

"We hope to design a vapor sensor that has ultra-high sensitivity, specific and rapid response to a certain molecule, as well as the ability of on-the-spot chemical analyses, which usually requires the sensor to be small, portable, reusable, and have less power consumption," said Professor Fan.

Related Links:

University of Missouri



New
Gold Member
Clinical Drug Testing Panel
DOA Urine MultiPlex
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Capillary Blood Collection Tube
IMPROMINI M3
Automatic CLIA Analyzer
Shine i9000
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.